Oncternal Therapeutics Inc
(ONCT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2003 | 12-2002 | 12-2001 | |
| Operating Expenses | 14,337 | 12,022 | 8,146 |
| Operating Income | -14,337 | -12,022 | -8,146 |
| Other Income | 143 | 156 | 83 |
| Pre-tax Income | -14,194 | -11,866 | -8,063 |
| Net Income Continuous | -14,194 | -11,866 | -8,063 |
| Net Income | $-14,194 | $-11,866 | $-8,063 |
| EPS Basic Total Ops | -17,270.82 | -3,848.85 | -1,609.52 |
| EPS Basic Continuous Ops | -2,568.28 | -2,147.05 | -1,458.93 |
| EPS Diluted Total Ops | -17,270.82 | -3,848.85 | -1,609.52 |
| EPS Diluted Continuous Ops | -2,568.28 | -2,147.05 | -1,458.93 |
| EBITDA(a) | $-13,980 | $-11,690 | $-7,931 |